Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastric stem cells: an update.

Irvin M Modlin1, Mark Kidd, Kevin D Lye

  • 1Gastrointestinal Surgical Pathobiology Research Group, Department of Surgery, Yale University School of Medicine, New Haven, CT 06520-8062, USA.

The Keio Journal of Medicine
|July 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical Validation of NETest2.0<sup>®</sup>, a Novel Multigene Blood-Based Molecular Assay for Neuroendocrine Tumors.

Cancers·2026
Same author

Clinical Utility of PROSTest: A Prospective Study Suggesting Reduction in Unnecessary MRI and Biopsy in Men Evaluated for Prostate Cancer.

Cancers·2026
Same author

Comparative Blood-Based Transcriptomic Profiles of Prostate Cancer Patients from South Africa and the USA: A Cross-Sectional Pilot Study.

Journal of Cancer·2026
Same author

Utility of the PROSTest, a Novel Blood-Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease.

The Prostate·2025
Same author

PROSTest, a Multigene Liquid Biopsy Signature, Effectively Stratifies Patients With High PSA for Prostate Biopsy.

The Prostate·2025
Same author

Clinical Sensitivity and Specificity of the PROSTest in an American Cohort.

The Prostate·2025
Same journal

Transcript of the Commemorative Lecture by Dr. Akiko Iwasaki (30th Keio Medical Science Prize Award Ceremony).

The Keio journal of medicine·2026
Same journal

Association of Loneliness and Health Literacy with Overuse of Over-the-counter Drugs in Patients with COVID-19 in Japan.

The Keio journal of medicine·2026
Same journal

Ligustilide Attenuates Neuroinflammation and Fibrosis in an Aluminum Chloride-induced Rat Model of Alzheimer's Disease via mTOR/STAT3 Signaling Inhibition.

The Keio journal of medicine·2026
Same journal

Community Pharmacists' Attitudes and Experiences Regarding the Promotion of Vaccinations in Japan.

The Keio journal of medicine·2026
Same journal

Identifying High-Cost RSV Hospitalizations at a Secondary Hospital in Japan.

The Keio journal of medicine·2026
Same journal

Comparison of Clinical Development of Digital Therapeutics among Japan, the Unites States, and Germany.

The Keio journal of medicine·2025
See all related articles

Gastric stem cells in the stomach lining regenerate all cell types and repair damage. Understanding these cells and their niche interactions offers new therapeutic targets for gastric diseases.

Area of Science:

  • Gastroenterology
  • Stem Cell Biology
  • Molecular Biology

Background:

  • Gastric mucosa cells renew constantly, with rates influenced by inflammation, ulceration, and carcinogenesis.
  • Research is shifting focus from mucosal damage to understanding gastric stem cell lineages and phenotype regulators for therapeutic insights.

Discussion:

  • Chimeric and X-inactivation studies reveal distinct morphological diversity across gastric regions (antrum vs. fundus).
  • Evidence suggests a single gastric stem cell per gland generates all differentiated cells via committed progenitors.
  • This multipotent stem cell is implicated in crypt formation, repair, and the development of ulcer-associated lineages and gastric carcinomas.

Key Insights:

  • A specific stem cell niche in the isthmus, involving mesenchymal cells and extracellular matrix, likely regulates stem cell function through mesenchymal-epithelial cross talk.

Related Experiment Videos

  • Molecular pathways, such as Insulin-like Growth Factor (IGF) signaling, are beginning to be understood in gastric gland development.

    • Outlook:

    • Identifying these regulatory pathways is crucial for discovering novel molecular targets for treating gastric diseases.
    • Further research into gastric stem cell biology and niche interactions promises significant advancements in gastroenterological therapies.